Header Logo

Connection

Elisa Lee to Cardiovascular Diseases

Back to Details
This is a "connection" page, showing publications Elisa Lee has written about Cardiovascular Diseases.
Elisa Lee
Connection Strength
3.647
Cardiovascular Diseases
  1. A cardiovascular risk reduction program for American Indians with metabolic syndrome: the Balance Study. J Prim Prev. 2012 Aug; 33(4):187-96.
    View in: PubMed
    Score: 0.312
  2. Obesity in adults is associated with reduced lung function in metabolic syndrome and diabetes: the Strong Heart Study. Diabetes Care. 2011 Oct; 34(10):2306-13.
    View in: PubMed
    Score: 0.292
  3. Albuminuria within the "normal" range and risk of cardiovascular disease and death in American Indians: the Strong Heart Study. Am J Kidney Dis. 2007 Feb; 49(2):208-16.
    View in: PubMed
    Score: 0.213
  4. Dyslipidemia in American Indian Adolescents and Young Adults: Strong Heart Family Study. J Am Heart Assoc. 2024 Mar 19; 13(6):e031741.
    View in: PubMed
    Score: 0.174
  5. Subclinical atherosclerosis in adolescents and young adults and the risk of cardiovascular disease: The Strong Heart Family Study (SHFS). Nutr Metab Cardiovasc Dis. 2022 08; 32(8):1863-1871.
    View in: PubMed
    Score: 0.154
  6. Trends in Cardiovascular Disease Morbidity and Mortality in American Indians Over 25 Years: The Strong Heart Study. J Am Heart Assoc. 2019 11 05; 8(21):e012289.
    View in: PubMed
    Score: 0.129
  7. Red meat consumption and cardiovascular target organ damage (from the Strong Heart Study). J Hypertens. 2017 09; 35(9):1794-1800.
    View in: PubMed
    Score: 0.111
  8. Leukocyte telomere length and ideal cardiovascular health in American Indians: the Strong Heart Family Study. Eur J Epidemiol. 2017 01; 32(1):67-75.
    View in: PubMed
    Score: 0.104
  9. Smoking-attributable mortality in American Indians: findings from the Strong Heart Study. Eur J Epidemiol. 2015 Jul; 30(7):553-61.
    View in: PubMed
    Score: 0.095
  10. Joint association of nicotinic acetylcholine receptor variants with abdominal obesity in American Indians: the Strong Heart Family Study. PLoS One. 2014; 9(7):e102220.
    View in: PubMed
    Score: 0.089
  11. Insulin resistance, incident cardiovascular diseases, and decreased kidney function among nondiabetic American Indians: the Strong Heart Study. Diabetes Care. 2013 Oct; 36(10):3195-200.
    View in: PubMed
    Score: 0.083
  12. Community-responsive interventions to reduce cardiovascular risk in American Indians. J Prim Prev. 2012 Aug; 33(4):153-9.
    View in: PubMed
    Score: 0.078
  13. Estimated GFR and incident cardiovascular disease events in American Indians: the Strong Heart Study. Am J Kidney Dis. 2012 Nov; 60(5):795-803.
    View in: PubMed
    Score: 0.078
  14. Lipoprotein-associated phospholipase A(2) mass and activity and risk of cardiovascular disease in a population with high prevalences of obesity and diabetes: the Strong Heart Study. Diabetes Care. 2012 Apr; 35(4):840-7.
    View in: PubMed
    Score: 0.076
  15. Hemoglobin A1c, fasting glucose, and cardiovascular risk in a population with high prevalence of diabetes: the strong heart study. Diabetes Care. 2011 Sep; 34(9):1952-8.
    View in: PubMed
    Score: 0.073
  16. Tobacco use and cardiovascular disease among American Indians: the strong heart study. Int J Environ Res Public Health. 2010 10; 7(10):3816-30.
    View in: PubMed
    Score: 0.069
  17. Achieving lipid targets in adults with type 2 diabetes: the Stop Atherosclerosis in Native Diabetics Study. J Clin Lipidol. 2010 Sep-Oct; 4(5):435-43.
    View in: PubMed
    Score: 0.068
  18. High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. J Am Coll Cardiol. 2009 Oct 27; 54(18):1730-4.
    View in: PubMed
    Score: 0.064
  19. Prognostic value of multiple biomarkers in American Indians free of clinically overt cardiovascular disease (from the Strong Heart Study). Am J Cardiol. 2009 Jul 15; 104(2):247-53.
    View in: PubMed
    Score: 0.063
  20. Genetic and other factors determining mannose-binding lectin levels in American Indians: the Strong Heart Study. BMC Med Genet. 2009 Jan 22; 10:5.
    View in: PubMed
    Score: 0.061
  21. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study. Diabetes Care. 2007 Jul; 30(7):1851-6.
    View in: PubMed
    Score: 0.054
  22. Aging and the prevalence of cardiovascular disease risk factors in older American Indians: the Strong Heart Study. J Am Geriatr Soc. 2007 Jan; 55(1):87-94.
    View in: PubMed
    Score: 0.053
  23. Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care. 2006 Feb; 29(2):391-7.
    View in: PubMed
    Score: 0.050
  24. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension. 2006 Mar; 47(3):410-4.
    View in: PubMed
    Score: 0.050
  25. A longitudinal study of hypertension risk factors and their relation to cardiovascular disease: the Strong Heart Study. Hypertension. 2006 Mar; 47(3):403-9.
    View in: PubMed
    Score: 0.050
  26. Left atrial systolic force and cardiovascular outcome. The Strong Heart Study. Am J Hypertens. 2005 Dec; 18(12 Pt 1):1570-6; discussion 1577.
    View in: PubMed
    Score: 0.049
  27. Repolarization abnormality for prediction of all-cause and cardiovascular mortality in American Indians: the Strong Heart Study. J Cardiovasc Electrophysiol. 2005 Sep; 16(9):945-51.
    View in: PubMed
    Score: 0.048
  28. C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study. Circulation. 2005 Aug 30; 112(9):1289-95.
    View in: PubMed
    Score: 0.048
  29. Hysterectomy prevalence and cardiovascular disease risk factors in American Indian women. Maturitas. 2005 Nov-Dec; 52(3-4):328-36.
    View in: PubMed
    Score: 0.048
  30. C-reactive protein and electrocardiographic ST-segment depression additively predict mortality: the Strong Heart Study. J Am Coll Cardiol. 2005 Jun 07; 45(11):1787-93.
    View in: PubMed
    Score: 0.048
  31. Correlation between lipoprotein(a) and other risk factors for cardiovascular disease and diabetes in Cherokee Indians: the Cherokee Diabetes Study. Ann Epidemiol. 2005 May; 15(5):390-7.
    View in: PubMed
    Score: 0.047
  32. Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. Am J Hypertens. 2005 Feb; 18(2 Pt 1):191-6.
    View in: PubMed
    Score: 0.046
  33. Incidence of lower-extremity amputation in American Indians: the Strong Heart Study. Diabetes Care. 2004 Aug; 27(8):1885-91.
    View in: PubMed
    Score: 0.045
  34. Relation of lower-extremity amputation to all-cause and cardiovascular disease mortality in American Indians: the Strong Heart Study. Diabetes Care. 2004 Jun; 27(6):1286-93.
    View in: PubMed
    Score: 0.044
  35. Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: the strong heart study. Diabetes. 2004 Feb; 53(2):434-40.
    View in: PubMed
    Score: 0.043
  36. Prognostic implications of ejection fraction from linear echocardiographic dimensions: the Strong Heart Study. Am Heart J. 2003 Sep; 146(3):527-34.
    View in: PubMed
    Score: 0.042
  37. An appraisal of echocardiography as an epidemiological tool. The Strong Heart Study. Ann Epidemiol. 2003 Apr; 13(4):238-44.
    View in: PubMed
    Score: 0.041
  38. Evidence for distinct genetic effects on obesity and lipid-related CVD risk factors in diabetic compared to nondiabetic American Indians: the Strong Heart Family Study. Diabetes Metab Res Rev. 2003 Mar-Apr; 19(2):140-7.
    View in: PubMed
    Score: 0.041
  39. Genetic and environmental contributions to cardiovascular disease risk in American Indians: the strong heart family study. Am J Epidemiol. 2003 Feb 15; 157(4):303-14.
    View in: PubMed
    Score: 0.040
  40. Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study. J Am Coll Cardiol. 2002 Dec 04; 40(11):1984-90.
    View in: PubMed
    Score: 0.040
  41. Heritability of carotid artery structure and function: the Strong Heart Family Study. Arterioscler Thromb Vasc Biol. 2002 Oct 01; 22(10):1698-703.
    View in: PubMed
    Score: 0.039
  42. Principal component analysis of the T wave and prediction of cardiovascular mortality in American Indians: the Strong Heart Study. Circulation. 2002 Feb 12; 105(6):714-9.
    View in: PubMed
    Score: 0.038
  43. Changes in cardiovascular disease risk factors among American Indians. The Strong Heart Study. Ann Epidemiol. 2002 Feb; 12(2):97-106.
    View in: PubMed
    Score: 0.038
  44. Lipoprotein(a) in American Indians is low and not independently associated with cardiovascular disease. The Strong Heart Study. Ann Epidemiol. 2002 Feb; 12(2):107-14.
    View in: PubMed
    Score: 0.038
  45. Telomere length and cancer mortality in American Indians: the Strong Heart Study. Geroscience. 2019 06; 41(3):351-361.
    View in: PubMed
    Score: 0.031
  46. QTL mapping of leukocyte telomere length in American Indians: the Strong Heart Family Study. Aging (Albany NY). 2013 Sep; 5(9):704-16.
    View in: PubMed
    Score: 0.021
  47. Incremental value of biochemical and echocardiographic measures in prediction of ischemic stroke: the Strong Heart Study. Stroke. 2012 Mar; 43(3):720-6.
    View in: PubMed
    Score: 0.019
  48. Bivariate genetic association of KIAA1797 with heart rate in American Indians: the Strong Heart Family Study. Hum Mol Genet. 2010 Sep 15; 19(18):3662-71.
    View in: PubMed
    Score: 0.017
  49. Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) . J Clin Lipidol. 2010 May-Jun; 4(3):165-72.
    View in: PubMed
    Score: 0.017
  50. The association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family Study. Hum Genet. 2010 Mar; 127(3):295-301.
    View in: PubMed
    Score: 0.016
  51. Prevalence and prognostic significance of wall-motion abnormalities in adults without clinically recognized cardiovascular disease: the Strong Heart Study. Circulation. 2007 Jul 10; 116(2):143-50.
    View in: PubMed
    Score: 0.014
  52. Utility of the myocardial performance index in a population with high prevalences of obesity, diabetes, and hypertension: the strong heart study. Echocardiography. 2007 Apr; 24(4):340-7.
    View in: PubMed
    Score: 0.013
  53. Mitral annular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovascular disease: the Strong Heart Study. Stroke. 2005 Dec; 36(12):2533-7.
    View in: PubMed
    Score: 0.012
  54. Combined echocardiographic left ventricular hypertrophy and electrocardiographic ST depression improve prediction of mortality in American Indians: the Strong Heart Study. Hypertension. 2004 Apr; 43(4):769-74.
    View in: PubMed
    Score: 0.011
  55. Genetic determination of acute phase reactant levels: the strong heart study. Hum Hered. 2004; 58(2):112-6.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.